Successful cancer biotech entrepreneur with $394m exit, founds new ASX listed cancer biotech company
This successful industry entrepreneur, who sold his previous cancer focused biotech company for $394m, has founded a ASX listed cancer focused biotech company.
Successful biotechnology entrepreneur with a AUD60m exit, starts next biotechnology venture
Matthew Callahan was the Founder and CEO of iCeutica, which was acquired by Iroko Pharmaceuticals for AUD60m in 2011.
